Abstract
INTRODUCTION
Fluctuating vision can be very frustrating for a patient due to its transient and unpredictable nature, which can affect daily tasks, such as reading, driving, and computer use. Common factors that may contribute to fluctuating vision include ocular-surface anomalies (e.g., corneal dystrophy, dry eye), diabetes and hormonal changes (e.g., during pregnancy). 1 Poor vision may also be due to uncorrected refractive error, ocular media opacity (i.e., corneal, lenticular, or vitreal) and retinal conditions. Dry eye (DE) disease is a widely prevalent condition, 2 which is often accompanied by symptoms of ocular discomfort and vision disturbances, 3 that affects many aspects of a patient's quality of life. [4] [5] [6] Fluctuating vision and ocular discomfort are major reasons why patients consult eye care practitioners (ECP). 2, 7 The cornea needs to remain clear for proper vision. However, in some cases, alterations to any of the layers of the cornea can affect its transparency and ultimately its function. Corneal dystrophies are a group of genetic disorders that cause alterations to the cornea and affect its transparency. 8, 9 Corneal dystrophies arise from a progressive accumulation of abnormal material in any of the layers of the cornea, without inflammation, infection, or neovascularization. 1, 10, 11 Since most corneal dystrophies follow an autosomal dominant inheritance pattern, the examination of family members can be useful for confirming the diagnosis. 1, 10, 12, 13 These dystrophies are progressive in nature, bilateral, but not always symmetrical, 1, 9, 11, 12 and, depending on the layer of the cornea affected, may or may not lead to vision changes. 10, 11, 13 Traditionally, corneal dystrophies are classified by the anatomical location of the opacity; i.e., anterior (epithelium/ Bowman's layer), stromal or endothelial. While some are encountered more commonly than others, Table 1 12-17 summarizes corneal dystrophies according to their effect on vision, which may assist ECPs in differentiating among them. ® (Pfizer) for her depression, vitamins (E and C) and omega-3 supplements. Her ocular history revealed longstanding complaints of DE, fluctuating vision, pain, irritation and a gritty sensation in both eyes. The patient also reported dryness of the mouth, throat, and nose; she tested negative for Sjögren's syndrome. Additionally, macular drusen were noted and age-related macular degeneration (ARMD) was diagnosed, for which she takes vitamins (Vitalux ® , ALCON) and is being followed by a retinal specialist. Mild nuclear sclerosis (grade 1) was noted in both eyes. The patient reported using artificial tears (Systane ® ULTRA, ALCON) 8X/day and an ocular ointment at bedtime (Liposic ® gel, Bausch + Lomb) to address her ocular discomfort. She remained unsatisfied with her vision despite her new glasses and continued to report ocular discomfort.
A comprehensive DE evaluation revealed severe symptoms (score of 87.5/100) using the Ocular Surface Disease Index (OSDI) questionnaire. Other tear tests were performed and the results are summarized in Table 2 ; most values were within normal limits. Distance acuities were similar to those reported at the annual eye exam (OD 6/7.5
+2
; OS 6/6
; OU 6/6 -1
). The near acuity revealed less than optimal results (OD 0.8 M; OS 1.0 M at 40 cm using a near point card), which differed from the results at her check-up 5 months previously (OD 0.37; OS 0.50 M at 50 cm). A detailed anterior segment evaluation revealed redness (telangiectasia) along the eyelid margin, clear gelatinous deposits at the base of a few lashes resembling cylindrical dandruff (CD) and several differently shaped translucent corneal opacities in both eyes. Epilation was performed on the lashes that had CD and a microscopic evaluation confirmed the presence of Demodex folliculorum, a common lash mite. Meibomian gland assessment revealed difficulty with expression along with yellow, liquid secretions. Meibography (Meiboscan, 5M Keratograph, Oculus) revealed non-linear and partially filled Meibomian glands in all four eyelids. Ocular staining revealed upper lid margin staining (ULMS) along the full length of the upper palpebral conjunctiva, with a 20% thickness profile (Table 2 ).
C
The corneal opacities varied with respect to both shape and size, and could be described as irregular gray geographic patches (resembling ground-glass) and clustered, whorl-like patterns resembling a fingerprint ( Figs. 1 and 2 ). These were observed under white illumination with an oblique broad beam, but were more evident with fluorescein instillation (Fig. 3) . No epithelial defects were noted in either eye. While both eyes presented opacities in the pupillary axis, the dystrophy was more advanced in the left eye, which partly contributed to the reduced near acuity. The corneal opacities were photodocumented to establish a baseline and to educate the patient. Management for MGD included daily warm compresses using a face towel for 5-10 minutes followed by ocular massage. Since the patient did not own a microwave, eyelid warming masks were not a feasible option. Consequently, patient education was important to explain how the warm face cloth needed to be alternated with another every 1-2 minutes to maintain heat on the eyelids. 18, 19 She was encouraged to continue with omega-3 supplementation.
The patient was educated on EBMD, including its permanent nature and associated fluctuating vision and the possibility of recurrent corneal erosions (RCE). Despite this explanation, the patient was still convinced that her subpar vision was due to her new glasses. Management was aimed at decreasing the fluctuating vision, reestablishing a smooth refractive surface, and limiting friction between the lid and the corneal surface. Hence, a non-preserved artificial tear with sodium hyaluronate (I-Drop ® Pur Gel, I-Med Pharma Inc.) was recommended at least 4X/day to both reduce friction (ULMS) and enhance the tear layer over the irregular ocular surface (EBMD).
Since the patient was distraught over the EBMD and the fact that her dissatisfaction with her vision may be more permanent than she had anticipated, a discussion about the anterior blepharitis secondary to Demodex was delayed for a follow-up visit 4 months later. The patient was properly counseled on the contributing etiologies of her symptoms, which included discomfort and fluctuating vision. Patient education included information on EBMD, dry eyes, cataracts, and ARMD. Although she was still disgruntled, the patient left with a better understanding of the causes of her fluctuating vision and ocular discomfort.
DISCUSSION
This case exemplifies how EBMD, coupled with DE, can contribute to a patient's symptoms of unstable vision and discomfort. Patients typically assume that all vision problems are correctable. However, in this case, the patient needed to be properly educated about the multifaceted etiology of her condition, which may not be completely resolvable. Patients need to be reminded that several components of the eye are responsible for creating optimal vision, from the tear film to the retina. Consequently, any disturbances along that path may contribute to poor/unstable vision. In this case, the tear film, cornea, lens and retina were compromised, and thus extra time was dedicated to educate the patient appropriately. The patient's complaints were focused on fluctuating blurred vision, irritation and pain, despite the lack of any apparent RCE and an updated refraction. A brief discussion of corneal dystrophies with particular attention to EBMD was necessary for the patient to understand its contribution to overall vision.
EBMD is the most common corneal dystrophy. 9, 16 Although EBMD can occur sporadically, there have been some cases of autosomal dominant inheritance. 9, 14, 20 EBMD is defined by a triad of characteristic corneal changes, notably grey geographic patches (referred to as 'Map'), gray-white round or oblong opacities ('Dot'), and curvilinear refractile clustered lines ('Fingerprint'). 15, 21 Hence EBMD has also been described as Map-Dot-Fingerprint dystrophy to reflect the patterns observed on the cornea, and may present some or all of these three features. 20 Symptoms include blurry vision, grittiness, foreign body sensation, and pain (especially during RCE episodes).
20, 22, 23
Histopathology of these opacities reveals thickening of the epithelial basement membrane with abnormal extensions into the overlying epithelium. 12, 20 With the use of fluorescein, these elevated areas appear as negative staining and contribute to decreased tear-film stability.
14, 24 Furthermore, these projections inhibit the normal surface migration of maturing epithelial cells, resulting in cysts containing cellular debris from the degenerating cells. 12 Epithelial cells have hemidesmosomes to reinforce their anchoring to the basement membrane. In EBMD, epithelial cells anterior to the abnormal basement membrane are unable to form hemidesmosomes, which causes poor adherence. 20 Due to this frail attachment, the epithelial layer can easily be separated, causing RCE in 10% of these patients; asymptomatic patients can quickly become severely symptomatic. 1, 9, 21 When differentiating between corneal opacities, an ECP will consider age of onset, effect on vision and location and appearance of opacities to render a diagnosis. Age of onset is a poor parameter to distinguish between epithelial dystrophies as they all typically occur by the first and/or second decade of life.
12-14 EBMD, which is an exception, appears in early adulthood. 12, 14, 16 Although the present patient was an adult, the age of onset was unknown and therefore could not be used to help in the differential diagnosis.
The effect on vision can be used to distinguish between corneal dystrophies (Table 1) . Reis-Bücklers and ThielBehnke dystrophies, for example, may be associated with a marked reduction in acuity, while EBMD and Meesmann dystrophy have the potential to impact vision. 12, 13 However, in this patient, fluctuating vision was a poor differentiating indicator because there were other contributing factors, such as DE, cataracts and ARMD. Therefore, in her case, anterior and posterior segment photography was warranted along with strict follow-up to best identify which condition will progressively affect her vision.
Symptoms of ocular discomfort and pain, which this patient reported, also may occur in DE and corneal dystrophies (with the presence of RCE). This patient had no visible RCE at the time of consultation, yet she reported pain, which may be linked to her ocular-surface dryness. Furthermore, the possibility of RCE was discussed, along with the associated abrupt onset of pain, which may occur and prompt consultation. Although RCEs are possible in any of the epithelial dystrophies, 13, 25 people may not consult an ECP due to the variability in pain sensation and discomfort that they may experience.
Consequently, age of onset, effect on vision, and pain are not reliable indicators for identifying a corneal pathology. As a result, the location and appearance of the opacities remain the principal factors in the diagnosis of epithelial dystrophies. 25 It is unlikely that an average practitioner would have clinical experience with the full scope of corneal dystrophies, unless in a corneal specialty practice. Hence, an atlas would be a useful resource for clarifying the clinical presentation of opacities. Table 3 1, 13, 14, 21, 25 provides some clinical pearls to associate characteristic features of corneal opacities with the related epithelial dystrophy. The present case represents a typical EBMD, with representative photographs, in that the clinical presentation included characteristic Map-and Fingerprint-like corneal opacities. In this patient, DE was evaporative (MGD), frictional (ULMS) and inflammatory (blepharitis). These conditions are all attracting interest in the optometric field and little is known about their pathophysiology and management. For now, treatment for this patient was limited to artificial tears and warm compresses, and an information sheet was provided to increase her understanding and compliance.
CONCLUSION
Visual impairment, whether permanent or not, is very disconcerting to patients. Consequently, an ECP needs to take time to educate their patient appropriately on contributory factors that can affect vision, such as corneal dystrophies. Although this patient initially presented with frustration regarding her vision and ocular discomfort, patient education allowed her to gain a better understanding of her conditions, especially with regard to EBMD and DE. The use of anterior segment photography proved to be a powerful tool for promoting the patient's understanding and hopefully improving compliance with the recommended management. 
